# Pro BNP Test for Feline and Canine Heart Disease: Screening and Limits ## Key Takeaways - The NT-proBNP test measures N-terminal pro-B-type natriuretic peptide, a biomarker released by heart muscle cells under stress, indicating increased myocardial workload due to factors like volume or pressure overload. - In cats, NT-proBNP is valuable for screening asymptomatic (occult) hypertrophic cardiomyopathy (HCM) and differentiating cardiac from respiratory causes of dyspnea, though it has overlap with normal ranges and cannot replace echocardiography. - In dogs, NT-proBNP serves as a severity marker for myxomatous mitral valve disease (MMVD) and monitors heart failure progression, but it is less useful for early screening and does not quantify regurgitation, necessitating echocardiography and radiography. - The Pro BNP test is a diagnostic aid, not a standalone test; it must be interpreted alongside physical examination findings, thoracic radiographs (e.g., Vertebral Heart Score), and echocardiography, which remains the gold standard for structural heart disease diagnosis. - Immediate veterinary attention is crucial for pets exhibiting emergency signs such as difficulty breathing, coughing, fainting, lethargy, or paralysis, as these are not conditions to be managed with home diagnostics alone. --- If your veterinarian recommends a Pro BNP test, often called NT-proBNP, they are looking for a blood marker that helps assess heart muscle stress. This test is a valuable tool for screening asymptomatic pets for occult (hidden) heart disease and for helping to distinguish cardiac from respiratory causes of breathing difficulty. However, it is not a perfect test. The Pro BNP test has specific limits, and it cannot replace a full cardiac workup, particularly echocardiography. **Owner Triage Summary:** If your pet is showing signs of heart disease, such as a new cough, rapid breathing, lethargy, or fainting, do not rely on a home Pro BNP test alone. These signs are emergencies. A Pro BNP test is a diagnostic aid used by veterinarians, not a substitute for a physical exam or imaging. If your pet is asymptomatic but you are concerned about breed predisposition, discuss screening with your vet. A single normal Pro BNP result does not guarantee a healthy heart, and an elevated result does not always mean heart failure is present. ## At a Glance: Pro BNP Test for Feline and Canine Heart Disease | Feature | Cats (Feline) | Dogs (Canine) | | :--- | :--- | :--- | | **Primary Use** | Screening for occult cardiomyopathy (HCM) and differentiating cardiac vs. respiratory dyspnea [1]. | Assessing severity of myxomatous mitral valve disease (MMVD) and monitoring heart failure [2]. | | **What It Measures** | N-terminal pro-B-type natriuretic peptide, released from heart muscle cells under stress [1]. | N-terminal pro-B-type natriuretic peptide, released from heart muscle cells under stress [2]. | | **Screening Value** | Can distinguish asymptomatic cats with cardiomyopathy from normal cats, but with overlap [1]. | Useful for monitoring disease progression and gut microbiota correlations, but less useful for early screening [2]. | | **Diagnostic Limits** | Cannot replace echocardiography; false positives and negatives occur; not a stand-alone test [1][3]. | Values correlate with disease severity but are not a substitute for echocardiography or radiography [4][5]. | | **Key Clinical Context** | Elevated levels correlate with left atrial enlargement and troponin levels [1]. | Elevated levels are associated with CHF and systemic inflammation [2][6]. | ## Understanding the Pro BNP Test: Anatomy and Physiology The heart is a muscular pump. When its chambers stretch or the muscle wall experiences increased tension, cardiac muscle cells release prohormones. These are cleaved into the active hormone (B-type natriuretic peptide, BNP) and an inactive N-terminal fragment (NT-proBNP). This N-terminal fragment is more stable in the blood, making it a reliable biomarker for measurement [1]. In both cats and dogs, NT-proBNP is a quantitative marker of myocardial stress. It is not a specific disease marker. Instead, it indicates that the heart is working harder than normal, which can happen in various conditions, including hypertrophic cardiomyopathy (HCM) in cats, myxomatous mitral valve disease (MMVD) in dogs, and other cardiac pathologies [1][2]. ### What the Test Measures The Pro BNP test measures the concentration of NT-proBNP in the blood. Higher concentrations generally indicate greater cardiac wall stress. This can be due to: - **Volume overload:** As seen in mitral regurgitation, where blood leaks backward, causing volume overload in the left atrium and ventricle [7]. - **Pressure overload:** As seen in conditions like pulmonic stenosis or systemic hypertension. - **Myocardial hypoxia or ischemia:** When the heart muscle does not get enough oxygen. ## Screening for Occult Heart Disease: The Role of Pro BNP The term "occult" means hidden. Many pets, especially cats, develop heart disease without showing any outward clinical signs. This is where the Pro BNP test is often considered as a screening tool. ### Pro BNP in Asymptomatic Cats A landmark multicenter study evaluated the use of NT-proBNP as a screening test for asymptomatic (occult) cardiomyopathy in cats [1]. The study compared 114 normal cats with 113 cats diagnosed with occult cardiomyopathy (OCM). The results were significant: - **NT-proBNP concentrations were significantly higher** in cats with OCM (median 186 pmol/L) compared to normal cats (median 24 pmol/L) [1]. - The test was particularly good at distinguishing cats with hypertrophic obstructive cardiomyopathy (HOCM) from those with non-obstructive HCM [1]. - **Correlation with severity:** NT-proBNP levels correlated positively with left ventricular posterior wall thickness (LVPWd), left atrial-to-aortic root ratio (LA/Ao), and troponin I levels, all of which are indicators of disease severity [1]. This suggests that Pro BNP can be a useful screening tool. However, the study also highlighted its limits. The ranges between normal and affected cats overlapped, meaning a normal result does not definitively rule out heart disease, and an elevated result does not definitively diagnose it. ### The Value of Focused Cardiac Ultrasound (FCU) The Pro BNP test is often compared to imaging. A 2019 study investigated whether focused cardiac ultrasound (FCU) performed by a nonspecialist practitioner could increase the detection of occult heart disease in asymptomatic cats compared to physical exam and ECG [3]. The study found that: - Agreement with a cardiologist's diagnosis was **slight after physical examination** (kappa 0.253) and did not improve after ECG [3]. - Agreement **increased significantly after FCU** (kappa 0.468) [3]. - Adding a point-of-care NT-proBNP assay (POC-BNP) to FCU did not significantly improve agreement further (kappa 0.498) [3]. This is a critical finding. It suggests that while Pro BNP adds value, imaging (even a focused ultrasound) is a more powerful tool for detecting structural heart disease. The Pro BNP test is best used as an adjunct to, not a replacement for, imaging. ## Pro BNP in Canine Heart Disease: Myxomatous Mitral Valve Disease (MMVD) In dogs, the most common acquired heart disease is myxomatous mitral valve disease (MMVD) [8][7][9]. This disease involves a progressive thickening of the mitral valve, leading to mitral regurgitation (backward flow of blood) [7][4]. ### Pro BNP as a Severity Marker NT-proBNP is a valuable marker for assessing the severity of MMVD. A 2026 study exploring gut microbiota in dogs with MMVD found that NT-proBNP concentrations were significantly increased in dogs with congestive heart failure (CHF) compared to those in the preclinical stage and healthy controls [2]. This confirms that NT-proBNP is a reliable indicator of hemodynamic decompensation. ### Correlation with Other Markers The Pro BNP test does not work in isolation. In dogs with MMVD, it is correlated with other physiological changes: - **Systemic Inflammation:** Dogs with cardiac disease exhibit systemic inflammation, which is associated with altered iron metabolism and decreased circulating iron [6]. This inflammation is part of the complex pathophysiology of heart failure. - **Renin-Angiotensin-Aldosterone System (RAAS):** In dogs with CHF, there is a strong inverse correlation between serum chloride and RAAS activation [10]. While not directly measuring Pro BNP, this highlights the complex hormonal and electrolyte imbalances that accompany heart failure, which Pro BNP levels can reflect indirectly through cardiac stress. ### The Limits of Pro BNP in Dogs While Pro BNP is useful, it has significant limits in canine patients: - **It does not quantify regurgitation:** Pro BNP levels reflect myocardial stress, but they do not directly measure the severity of mitral regurgitation. Quantitative echocardiographic variables like regurgitant volume and regurgitant fraction are needed for that [4]. - **It is not a screening tool for early MMVD:** In the early stages of MMVD (ACVIM stage B1), the heart is remodeling but not failing. Pro BNP may be normal or only mildly elevated. It is not sensitive enough to detect the subtle changes of early disease [4]. - **It cannot replace imaging:** Radiography (VHS) and echocardiography remain the gold standards for diagnosing and staging MMVD [9][11][5]. Pro BNP is a complementary test. ## Diagnostic Workflow: How Pro BNP Fits In The Pro BNP test is a piece of the diagnostic puzzle. It is not a standalone test. A comprehensive cardiac evaluation includes: 1. **Physical Examination:** Your veterinarian will listen for heart murmurs, arrhythmias, and lung sounds. They will also check for other signs like jugular vein distension or pale mucous membranes. 2. **Thoracic Radiographs (X-rays):** These are essential for evaluating heart size (using Vertebral Heart Score, VHS) and for detecting signs of congestive heart failure, such as pulmonary edema [9][11][12]. Breed-specific VHS reference intervals are critical for accurate interpretation [11]. 3. **Echocardiography (Ultrasound):** This is the gold standard for diagnosing structural heart disease. It allows the veterinarian to visualize the heart chambers, valves, and walls, and to measure cardiac function [3][13][7]. It can quantify mitral regurgitation severity and assess left atrial enlargement [4]. 4. **Electrocardiography (ECG):** This records the heart's electrical activity and can detect arrhythmias. 5. **NT-proBNP Blood Test:** This provides a biochemical measure of myocardial stress. It is most useful in: - **Cats with a murmur but no clinical signs:** To help decide if further testing is needed. - **Cats with respiratory distress:** To help differentiate between cardiac and respiratory causes of dyspnea. - **Dogs with known MMVD:** To monitor disease progression and guide therapy, particularly in the transition from preclinical to clinical heart failure. ## Evidence-Based Management and Monitoring The management of heart disease depends on the underlying cause, severity, and clinical stage. NT-proBNP can be used to monitor response to therapy. ### Monitoring Diuretic Therapy In dogs with CHF, loop diuretics like furosemide are the mainstay of therapy [8][14][15]. Monitoring the effectiveness of diuresis is critical. A 2026 study looked at spot urinary electrolytes to assess decongestion in dogs with acute CHF [14]. They found that higher urinary sodium concentration and a higher urinary sodium-to-potassium ratio were associated with greater improvement in pulmonary congestion and shorter hospitalization [14]. Another study examined diuretic responsiveness in dogs with chronic CHF and found that a consistently low urine sodium concentration (<70 mmol/L) indicated low diuretic responsiveness [15]. While these studies do not directly measure Pro BNP, they show the importance of monitoring the physiological response to therapy. Pro BNP can be used in conjunction with these markers to get a full picture of cardiac status. ### The Concept of "Stability" in MMVD The Pro BNP test is also useful in understanding the dynamic nature of heart disease. A rare case series described dogs with MMVD-related CHF that achieved stability and were able to discontinue loop diuretics [8]. These dogs were followed for over a year without needing diuretics. This suggests that in a small subset of patients, the factors contributing to CHF can be transient. Pro BNP levels, if monitored, would likely reflect this improvement. ## Unsafe Home Remedies and the Importance of Veterinary Care There are no safe or effective home remedies for heart disease in cats and dogs. The Pro BNP test is a diagnostic tool, not a treatment. Attempting to manage heart disease at home without a veterinary diagnosis is dangerous. - **Do not give human medications:** Human heart medications can be toxic to pets. - **Do not use over-the-counter supplements without veterinary approval:** Some supplements can interact with medications or worsen the condition. - **Do not restrict exercise without veterinary advice:** While rest is important during CHF, unnecessary restriction can lead to muscle loss. **Veterinary Disclaimer: This article is educational and is not a substitute for veterinary diagnosis or treatment.** ## Prevention and Prognosis ### Prevention There is no way to prevent the genetic predisposition to conditions like HCM in cats or MMVD in dogs. However, you can: - **Maintain a healthy weight:** Obesity increases the workload on the heart. - **Provide regular veterinary checkups:** Early detection of a murmur or other abnormality can lead to earlier intervention. - **Manage concurrent diseases:** Conditions like chronic kidney disease (CKD) can complicate heart disease management [16]. ### Prognosis The prognosis for heart disease varies greatly. - **Cats with HCM:** The prognosis is variable. Some cats live for years with minimal signs, while others progress to heart failure or thromboembolism. - **Dogs with MMVD:** The prognosis is also variable. Many dogs live for years in the preclinical stage. Once CHF develops, the prognosis is more guarded, but with appropriate therapy, many dogs can have a good quality of life for a significant period. The Pro BNP test can help provide prognostic information. Higher levels generally indicate more severe cardiac stress and a worse prognosis. ## Limitations and When to Contact a Veterinarian The Pro BNP test is a powerful tool, but it has inherent limitations that every pet owner should understand. - **It is not a standalone diagnostic test:** A Pro BNP result, whether high or low, is not a diagnosis. It must be interpreted in the context of the full clinical picture, including physical exam, radiographs, and echocardiography [1][3]. - **Breed-Specific Variations:** There are breed-specific variations in heart size and structure, as seen with VHS reference intervals [11]. It is likely that NT-proBNP concentrations also have breed-specific variations, although this is not fully defined. A value that is normal for one breed might be abnormal for another. - **Overlap in Results:** There is a significant overlap in NT-proBNP concentrations between healthy animals and those with mild heart disease [1]. This means a normal test cannot definitively rule out disease, and a mildly elevated test does not confirm it. - **Influence of Other Diseases:** NT-proBNP can be elevated in conditions other than primary heart disease, such as systemic hypertension or kidney disease, which can complicate interpretation [16]. - **What Breed-Level Information Cannot Predict:** A specific Pro BNP value cannot predict the exact day a pet will enter heart failure. It is a snapshot of cardiac stress at a single point in time. It cannot predict sudden death or the risk of thromboembolism in cats. **When to Contact a Veterinarian Immediately:** - **Difficulty breathing** (rapid breathing, open-mouth breathing, or breathing with effort). - **Coughing, especially at night or when resting.** - **Fainting or collapsing episodes.** - **Lethargy or weakness.** - **Loss of appetite.** - **A distended abdomen** (a sign of fluid accumulation). - **In cats: paralysis of the hind legs** (a sign of a saddle thrombus). These are all emergency red flags. Do not wait for a Pro BNP test result. Seek veterinary care immediately. ## The Clinical Reasoning Behind Ordering a Pro BNP Test Understanding why a veterinarian might reach for the Pro BNP test requires a shift in perspective from thinking of it as a "heart test" to thinking of it as a "stress test for heart muscle cells." The decision to measure NT-proBNP is rarely made in isolation. It is typically triggered by specific clinical scenarios, each with its own set of diagnostic questions that the test can help answer. ### The Asymptomatic Patient with a Murmur The most common scenario in feline practice is the apparently healthy [cat](/knowledge/veterinary-medicine/clinical-methods/cat) who is found to have a heart murmur during a routine wellness examination. The veterinarian is immediately faced with a clinical dilemma. The murmur could represent hemodynamically insignificant turbulence, or it could be the first audible sign of hypertrophic cardiomyopathy, the most common heart disease in cats. The physical examination cannot reliably distinguish between these possibilities, and many cats with HCM do not have an audible murmur at all. In this context, the Pro BNP test serves as a triage tool. A markedly elevated NT-proBNP concentration in a cat with a murmur increases the index of suspicion for clinically relevant disease and supports a recommendation for echocardiography. A normal result, while not definitive, may justify a more conservative approach with recheck examinations in six to twelve months. This is not about making a diagnosis from the blood test alone; it is about using the biomarker to stratify risk and allocate advanced diagnostics more efficiently. ### The Dyspneic Patient: Cardiac or Respiratory? Perhaps the most clinically valuable use of the Pro BNP test is in the emergency setting, specifically for the cat or [dog](/knowledge/veterinary-medicine/clinical-methods/dog) presenting with respiratory distress. The differential diagnosis for acute dyspnea includes congestive heart failure, primary respiratory disease such as [feline asthma](/knowledge/veterinary-medicine/clinical-methods/feline-asthma-diagnosis-management) or chronic bronchitis, and non-cardiac, non-respiratory causes like anemia or metabolic acidosis. The physical examination of a dyspneic patient is challenging. Auscultation may reveal crackles that could be pulmonary edema or could be airway disease. Radiographs may be difficult to obtain safely in a patient that is struggling to breathe. In this high-stakes scenario, a point-of-care NT-proBNP assay can provide rapid, objective information that helps the emergency clinician decide whether to initiate diuretic therapy or bronchodilator therapy. An elevated NT-proBNP in a dyspneic cat supports a cardiac cause and justifies cautious diuresis. A normal or low value makes heart failure less likely and steers the clinician toward respiratory causes. This distinction is critical because giving furosemide to a cat with severe asthma can worsen airway hydration and complicate the clinical picture, while withholding diuretics from a cat in pulmonary edema can be fatal. ### The Canine Patient with a Cough In dogs, the most common reason to consider Pro BNP testing is the presence of a cough in a middle-aged or older small breed dog. The cough could be due to myxomatous mitral valve disease with left atrial enlargement compressing the mainstem bronchus, or it could be due to tracheal collapse, chronic bronchitis, or pneumonia. The Pro BNP test helps differentiate these possibilities. A dog with MMVD and a cough due to bronchial compression will typically have elevated NT-proBNP because the left atrial enlargement creates myocardial stretch. A dog with tracheal collapse and a normal heart will have a normal NT-proBNP. This distinction guides further testing and therapy. If the Pro BNP is elevated, thoracic radiographs and possibly echocardiography are warranted to stage the disease. If it is normal, the clinician can focus on airway disease and pursue bronchoscopy or a therapeutic trial of cough suppressants and bronchodilators. ### Monitoring the Known Cardiac Patient For pets already diagnosed with heart disease, the Pro BNP test has a role in longitudinal monitoring. Serial measurements can track disease progression over time. A rising trend in NT-proBNP in a dog with preclinical MMVD may signal the transition to a more advanced stage, prompting earlier intervention or more frequent rechecks. In a cat with HCM, a stable or declining NT-proBNP on serial testing provides some reassurance that the disease is not rapidly progressing. The test is not a substitute for regular echocardiographic monitoring, but it adds a biochemical dimension that can be measured between imaging studies. This is particularly useful for owners who are trying to decide when to schedule the next cardiac ultrasound or for veterinarians who want to identify which patients need more intensive monitoring. ## The Diagnostic Workflow in Practice Integrating the Pro BNP test into a coherent diagnostic workflow requires an understanding of where the test adds value and where it does not. The following framework represents a practical approach used in many referral and primary care settings. ### Step One: Signalment, History, and Physical Examination Every cardiac evaluation begins with the basics. Breed, age, and sex provide important context. Cavalier King Charles Spaniels are predisposed to MMVD, while Maine Coon cats and Ragdoll cats have a higher prevalence of HCM. The history should include questions about exercise tolerance, respiratory rate at rest, coughing, syncope, and appetite. The physical examination should include cardiac auscultation in a quiet room, assessment of femoral pulse quality and character, mucous membrane color, capillary refill time, and jugular vein evaluation. The presence of a gallop rhythm or an arrhythmia on auscultation is a significant finding that warrants further investigation regardless of the Pro BNP result. ### Step Two: The Decision to Test The Pro BNP test is not indicated for every patient. It is most useful when the clinical picture is ambiguous. For a young dog with a soft, left apical systolic murmur and no other abnormalities, the pretest probability of significant heart disease is low, and a Pro BNP test may add little. For a senior cat with a murmur and a history of intermittent lethargy, the test has more value. The decision to test should be shared with the owner, who should understand that the result will be interpreted in the context of the physical examination and will not be a standalone diagnosis. ### Step Three: Point-of-Care Testing vs. Laboratory Submission The Pro BNP test can be run as a point-of-care assay in the veterinary clinic or submitted to a reference laboratory. Point-of-care testing provides results within minutes, which is invaluable in the emergency setting. Laboratory submission allows for batch testing and may be more cost-effective for non-urgent screening. The sample handling requirements differ between platforms, and the veterinarian will follow the manufacturer's instructions for the specific assay being used. Owners should be aware that the test requires a blood sample, typically a small volume of whole blood or serum, and that the results are typically available either immediately or within a few days depending on the testing method. ### Step Four: Interpretation in Context The Pro BNP result is never interpreted in a vacuum. A single elevated value in an asymptomatic cat does not mandate immediate therapy, but it does warrant further investigation. A normal value in a dog with radiographic evidence of cardiomegaly does not negate the imaging findings. The test is one piece of a diagnostic puzzle that also includes physical examination findings, thoracic radiographs, and echocardiography. The veterinarian will synthesize all of this information to arrive at a diagnosis and staging classification. ### Step Five: Actionable Outcomes The ultimate goal of the diagnostic workflow is to produce actionable outcomes. If the Pro BNP test is elevated in a cat with a murmur, the action is to recommend echocardiography. If the test is normal in a dyspneic cat, the action is to pursue respiratory diagnostics. If the test is rising in a dog with known MMVD, the action is to schedule a recheck examination and possibly adjust therapy. The test is a decision aid, not an endpoint. ## Evidence Limitations and the Challenge of Diagnostic Accuracy A responsible discussion of the Pro BNP test must acknowledge the limitations of the evidence base. While the test has been studied extensively, there are important gaps in our understanding that affect how the results should be interpreted in individual patients. ### The Problem of Overlap The landmark study in cats demonstrated a statistically significant difference in NT-proBNP concentrations between normal cats and cats with occult cardiomyopathy, but it also revealed substantial overlap between the two groups [1]. This means that for any given cutoff value, there will be false positives and false negatives. A cat with a mildly elevated NT-proBNP may have early HCM, or it may be a normal cat at the upper end of the reference range. A cat with a normal NT-proBNP may have mild disease that is not yet causing significant myocardial stress. This overlap is inherent to any biomarker and is not a flaw of the test itself, but it is a limitation that clinicians must acknowledge when interpreting results. ### The Reference Interval Problem Establishing a reference interval for NT-proBNP is challenging because the analyte is affected by multiple variables. Age, body weight, breed, and the presence of concurrent disease can all influence NT-proBNP concentrations. A reference interval derived from a population of young, healthy laboratory beagles may not be appropriate for a geriatric Maine Coon cat. Some studies have attempted to account for these variables, but the evidence is incomplete. This means that the interpretation of a Pro BNP result requires clinical judgment, not just a comparison to a printed reference range. ### The Lack of a True Gold Standard in All Cases Echocardiography is considered the gold standard for diagnosing structural heart disease, but it is not infallible. There is inter-observer variability in echocardiographic measurements, and mild disease can be missed even by experienced cardiologists. When the Pro BNP test is compared to echocardiography, the agreement is imperfect, and it is not always clear whether the discrepancy is due to a false positive Pro BNP or a false negative echocardiogram. This is a fundamental limitation of diagnostic accuracy studies in veterinary cardiology. ### The Problem of Spectrum Bias Diagnostic tests perform differently in different populations. A test that works well in a referral population with a high prevalence of disease may not perform as well in a primary care population with a lower prevalence. The positive predictive value of an elevated Pro BNP depends on the pretest probability of disease. In a population of cats with a high prevalence of HCM, an elevated Pro BNP is more likely to be a true positive. In a population of young, healthy cats, the same result is more likely to be a false positive. This is a statistical reality that owners should understand when their veterinarian discusses the meaning of a Pro BNP result. ### The Evolving Understanding of Canine MMVD The 2026 study exploring gut microbiota in dogs with MMVD represents an exciting frontier in veterinary cardiology [2]. The finding that NT-proBNP concentrations correlate with systemic inflammation and gut microbiota changes suggests that heart disease is not an isolated cardiac process but a systemic condition with far-reaching effects. However, this study also highlights how much we still do not know. The clinical implications of these microbiota changes are not yet clear, and it is too early to recommend probiotic therapy or dietary modifications based on this research. The study is a stepping stone, not a destination. ## What Owners Should Observe and Document Before the Veterinary Visit Owners are often the first to notice subtle changes in their pet's behavior that may indicate heart disease. The Pro BNP test is a snapshot taken at a single point in time, but the owner's observations provide the longitudinal context that makes the snapshot meaningful. Preparing for a veterinary visit by documenting specific observations can significantly improve the diagnostic process. ### Resting Respiratory Rate The single most valuable observation an owner can make is the resting respiratory rate. This is the number of breaths per minute when the pet is sleeping or resting quietly. The normal resting respiratory rate for a dog or cat is typically between 15 and 30 breaths per minute. An owner should count breaths over a full minute, ideally when the pet is in a deep sleep and has not been active for at least 30 minutes. A resting respiratory rate that is consistently above 30 breaths per minute, or that is trending upward over several days, can be an early indicator of pulmonary edema or pleural effusion. This observation is so valuable that it is often recommended for pets with known heart disease as a home monitoring tool. Owners should record the resting respiratory rate daily for several days before the veterinary visit and bring this log to the appointment. ### Coughing Patterns Not all coughs are the same. A cough due to heart disease is often described as a soft, moist cough that occurs at night or when the pet is lying down. A cough due to tracheal collapse is often a harsh, honking cough that occurs with excitement or pulling on the leash. A cough due to bronchitis is often productive and worse in the morning. Owners should note when the cough occurs, what the pet is doing at the time, whether the cough is productive or dry, and whether it is associated with exercise or excitement. This information helps the veterinarian differentiate cardiac from respiratory causes and guides the interpretation of the Pro BNP result. ### Activity Level and Exercise Tolerance Heart disease often manifests as a gradual decline in activity level. A dog that used to run for an hour may now tire after 15 minutes. A cat that used to jump onto the kitchen counter may now hesitate or fail to make the jump. Owners should note any changes in their pet's willingness to exercise, play, or engage in normal activities. They should also note whether the pet seems to recover more slowly after exertion. These observations provide important clues about cardiac reserve and functional capacity. ### Appetite and Weight Heart disease can affect appetite, either directly through nausea associated with congestive heart failure or indirectly through the general malaise that accompanies chronic illness. Owners should note any changes in appetite, food preferences, or the amount of food consumed. They should also weigh their pet regularly, ideally on the same scale at the same time of day. Unexplained weight loss can be a sign of chronic disease, while rapid weight gain can indicate fluid retention. ### Sleep and Resting Behavior Pets with heart disease often change their sleeping habits. They may sleep in different positions, such as sitting up rather than lying flat, to make breathing easier. They may seek out cooler surfaces or avoid lying on their side. They may also become restless at night, pacing or changing positions frequently. Owners should note any changes in their pet's sleep patterns or preferred resting positions. ### Episodes of Weakness or Collapse Any episode of weakness, collapse, or fainting is a red flag that warrants immediate veterinary attention. Owners should note the circumstances surrounding the episode, including what the pet was doing at the time, how long the episode lasted, and how the pet recovered. They should also note whether the pet seemed disoriented or confused after the episode. This information is critical for differentiating cardiac syncope from neurologic events. ## The Role of the Pro BNP Test in Preventive Care Preventive medicine in veterinary cardiology is about early detection and risk stratification. The Pro BNP test has a role in this process, but it is not a universal screening tool for all pets. ### Breed-Specific Screening Programs For breeds with a high prevalence of inherited heart disease, such as Maine Coon cats and Ragdoll cats for HCM, or Cavalier King Charles Spaniels for MMVD, regular cardiac screening is recommended. The Pro BNP test can be part of this screening program, but it should not be the only component. A comprehensive screening program includes regular physical examinations, auscultation for murmurs, and periodic echocardiography. The Pro BNP test can be used in between echocardiograms to identify cats that may need earlier imaging. However, the test is not sensitive enough to detect all cases of early disease, and a normal result should not delay a scheduled echocardiogram in a high-risk breed. ### The Healthy Senior Pet As pets age, the prevalence of heart disease increases. A Pro BNP test may be offered as part of a senior wellness panel for dogs and cats over seven years of age. This is a reasonable approach, but owners should understand the limitations. A normal result provides some reassurance, but it does not rule out heart disease. An elevated result warrants further investigation, but it does not confirm a diagnosis. The test is most useful when it is interpreted in the context of the complete senior wellness evaluation, including physical examination, blood work, and urinalysis. ### The Pet with Concurrent Disease The interpretation of the Pro BNP test is complicated by the presence of concurrent disease. Chronic kidney disease is common in senior cats and dogs, and it can affect NT-proBNP concentrations because the peptide is cleared by the kidneys [16]. Systemic hypertension, which is also common in senior pets, can increase myocardial wall stress and elevate NT-proBNP even in the absence of primary heart disease. Hyperthyroidism in cats can cause secondary cardiac changes and elevate NT-proBNP. Anemia can increase cardiac output and myocardial stress. When interpreting a Pro BNP result in a pet with concurrent disease, the veterinarian must consider whether the elevation is due to primary heart disease, the concurrent condition, or a combination of factors. This is a complex clinical judgment that cannot be reduced to a simple algorithm. ### The Role of Serial Monitoring The Pro BNP test is most valuable when it is used serially rather than as a one-time measurement. A single elevated value is difficult to interpret, but a rising trend over time is more concerning. A stable value over several measurements provides more reassurance. Owners of pets with known heart disease should discuss with their veterinarian whether serial Pro BNP monitoring is appropriate for their pet. The frequency of testing depends on the stage of disease, the rate of progression, and the treatment plan. ## Prognostic Information and Owner Expectations The Pro BNP test can provide prognostic information that helps owners prepare for the future. However, it is important to understand what the test can and cannot predict. ### What an Elevated Pro BNP Means for Prognosis In general, higher NT-proBNP concentrations are associated with a worse prognosis. A cat with a markedly elevated NT-proBNP is more likely to progress to congestive heart failure or develop arterial thromboembolism than a cat with a mildly elevated value. A dog with a rising NT-proBNP despite optimal medical therapy is more likely to experience decompensation than a dog with a stable value. This prognostic information can help owners make informed decisions about treatment intensity, monitoring frequency, and quality-of-life considerations. ### What the Test Cannot Predict The Pro BNP test cannot predict the exact timing of a cardiac event. A cat with an elevated NT-proBNP may remain stable for years, or it may develop heart failure within weeks. The test cannot predict sudden death, which can occur in cats with HCM even in the absence of prior clinical signs. The test cannot predict the risk of arterial thromboembolism, a devastating complication of feline heart disease. Owners should understand that the Pro BNP test provides a snapshot of cardiac stress at a single point in time, not a crystal ball for the future. ### Using Prognostic Information to Guide Decisions Prognostic information is most useful when it guides decisions. An elevated NT-proBNP in a cat with HCM may prompt more frequent monitoring, closer attention to resting respiratory rate, and earlier intervention if signs of heart failure develop. A rising NT-proBNP in a dog with MMVD may prompt a discussion about adding medications or adjusting the current regimen. The test can also help owners make decisions about quality of life. A pet with a markedly elevated NT-proBNP and declining clinical status may be approaching the end of life, and the owner may need to consider palliative care or humane euthanasia. ## Special Populations and Unique Considerations The Pro BNP test does not perform identically in all populations. There are important considerations for specific groups of pets that owners should be aware of. ### Cats with Concurrent Hyperthyroidism Hyperthyroidism is a common endocrinopathy in senior cats, and it has significant cardiac effects. The excess thyroid hormone increases heart rate, myocardial contractility, and oxygen demand, leading to myocardial stress and elevated NT-proBNP concentrations. This creates a diagnostic challenge. An elevated NT-proBNP in a hyperthyroid cat could be due to primary heart disease, the secondary cardiac effects of hyperthyroidism, or both. The standard approach is to treat the hyperthyroidism first and then reassess cardiac status once the cat is euthyroid. If the NT-proBNP remains elevated after thyroid hormone levels are normalized, primary heart disease is more likely. ### Cats with Chronic Kidney Disease Chronic kidney disease and heart disease frequently coexist in senior cats. The relationship between the two conditions is complex, with each potentially exacerbating the other. Kidney disease can elevate NT-proBNP through reduced clearance of the peptide, and it can also contribute to systemic hypertension, which increases myocardial wall stress [16]. When interpreting a Pro BNP result in a cat with kidney disease, the veterinarian must consider the stage of kidney disease and the presence of hypertension. This is a situation where the test result must be interpreted with particular caution. ### Brachycephalic Breeds Brachycephalic breeds, such as Bulldogs, Pugs, and French Bulldogs, present unique challenges in cardiac assessment. These breeds often have concurrent respiratory disease due to their flattened facial anatomy, which can cause coughing, exercise intolerance, and respiratory distress that mimics heart disease. The Pro BNP test can be helpful in differentiating cardiac from respiratory causes of these signs. However, the interpretation of the test in these breeds is complicated by the fact that chronic respiratory effort can increase intrathoracic pressure changes and potentially affect cardiac loading conditions. ### Athletic and Working Dogs Athletic and working dogs, such as racing Greyhounds, sled dogs, and agility competitors, have unique cardiac adaptations. Their hearts are often larger and more efficient than those of sedentary dogs, and their resting heart rates are lower. The reference intervals for NT-proBNP in these populations may differ from those of the general canine population. A value that is normal for a sedentary pet dog might be abnormal for a racing Greyhound, and vice versa. Owners of athletic dogs should ensure that their veterinarian is aware of the dog's activity level when interpreting a Pro BNP result. ### Geriatric Patients Age is a significant factor in the interpretation of the Pro BNP test. The prevalence of heart disease increases with age, but so does the prevalence of other conditions that can affect NT-proBNP concentrations. The geriatric patient is more likely to have concurrent kidney disease, hypertension, and other comorbidities that complicate interpretation. The Pro BNP test is still useful in this population, but the results must be interpreted with an understanding of the complete clinical picture. ## The Future of Cardiac Biomarkers The Pro BNP test is not the final word in veterinary cardiac biomarkers. Research is ongoing to identify new markers that may provide additional diagnostic and prognostic information. ### The Promise of Combined Biomarker Panels It is likely that the future of cardiac diagnostics lies in combined biomarker panels rather than single tests. A panel that includes NT-proBNP, cardiac troponin I, and markers of inflammation or fibrosis could provide a more complete picture of cardiac status than any single marker alone. The 2026 study exploring gut microbiota in dogs with MMVD suggests that markers of systemic inflammation may add value to the assessment of cardiac disease [2]. As our understanding of the pathophysiology of heart disease evolves, so too will our diagnostic tools. ### The Role of Genetics Genetic testing is becoming increasingly available for breeds with known inherited heart diseases. A genetic test for HCM in Maine Coon cats can identify cats that carry the mutation associated with the disease. However, not all cats with the mutation develop HCM, and not all cats with HCM have the known mutation. Genetic testing is a tool for risk assessment, not a diagnosis. It is likely that the Pro BNP test will be used in conjunction with genetic testing to identify cats that are at the highest risk of developing clinically significant disease. ### The Integration of Artificial Intelligence Artificial intelligence and machine learning are being explored as tools to improve the interpretation of diagnostic tests. An algorithm that integrates NT-proBNP concentrations with physical examination findings, echocardiographic measurements, and clinical history could potentially provide more accurate prognostic information than any single test. This is an exciting frontier, but it is not yet ready for clinical use. ## Practical Advice for Owners The Pro BNP test is a tool that can help veterinarians diagnose and manage heart disease in cats and dogs. Owners who understand the test, its strengths, and its limitations are better equipped to participate in their pet's care. ### Questions to Ask Your Veterinarian When your veterinarian recommends a Pro BNP test, you should feel empowered to ask questions. Why is the test being recommended? What will the result tell us? How will the result change the diagnostic or treatment plan? What are the limitations of the test? What are the alternatives to testing? A good veterinarian will welcome these questions and provide clear, honest answers. ### Understanding the Cost-Benefit The Pro BNP test has a cost, and owners should understand what they are paying for. The test provides information that can guide further diagnostics and treatment. In some cases, the test can save money by avoiding unnecessary echocardiography. In other cases, the test adds cost by prompting additional testing that might not have been performed otherwise. The value of the test depends on the clinical context. ### The Importance of the Complete Cardiac Evaluation The Pro BNP test is not a substitute for a complete cardiac evaluation. A physical examination, thoracic radiographs, and echocardiography provide information that a blood test cannot. Owners should not decline a recommended echocardiogram because a Pro BNP test was normal. Conversely, owners should not assume that an elevated Pro BNP test means their pet has a terminal disease. The test is a starting point, not an endpoint. ### The Role of the Owner in Monitoring Owners play a critical role in the ongoing management of heart disease. Monitoring the resting respiratory rate, observing for changes in activity level or appetite, and reporting any new signs to the veterinarian are all essential components of care. The Pro BNP test is a tool that the veterinarian uses, but the owner's observations are equally important. A pet with a normal Pro BNP but a rising resting respiratory rate is a cause for concern. A pet with an elevated Pro BNP but a stable resting respiratory rate and good quality of life may not require immediate intervention. ### The Emotional Reality of a Heart Disease Diagnosis A diagnosis of heart disease in a beloved pet is emotionally challenging. Owners may feel anxious, overwhelmed, or uncertain about the future. It is important to remember that many pets with heart disease live for years with a good quality of life. The Pro BNP test is a tool that helps veterinarians provide the best possible care, but it does not define the pet's worth or the owner's love. The bond between an owner and a pet is not measured in biomarkers. ## When to Seek Emergency Care The Pro BNP test is a diagnostic tool, not an emergency intervention. There are situations where immediate veterinary care is required, regardless of any test results. ### Recognizing the Signs of Congestive Heart Failure Congestive heart failure is a medical emergency. The signs include rapid breathing at rest, labored breathing, coughing, pale or blue gums, weakness, collapse, and in cats, paralysis of the hind limbs due to a saddle thrombus. If any of these signs are present, the pet needs immediate veterinary attention. Do not wait for a Pro BNP test result. Do not attempt to treat the pet at home. Transport the pet to the nearest veterinary emergency facility as quickly and safely as possible. ### The Danger of Delayed Care Delaying care for a pet in congestive heart failure can be fatal. The fluid that accumulates in the lungs or around the lungs makes it difficult for the pet to breathe, and the resulting hypoxia can damage other organs. Early intervention with oxygen therapy, diuretics, and other medications can stabilize the pet and improve the chances of a good outcome. The Pro BNP test can help the veterinarian confirm the diagnosis and guide therapy, but it is not a substitute for emergency treatment. ### The Importance of a Veterinary Relationship The best way to prepare for a cardiac emergency is to have an established relationship with a veterinarian. A veterinarian who knows your pet, your pet's medical history, and your pet's baseline status is better equipped to interpret test results and make treatment decisions. Regular wellness examinations, even in apparently healthy pets, provide the foundation for this relationship. The Pro BNP test is one tool in the veterinarian's arsenal, but the relationship between the owner, the pet, and the veterinarian is the most important factor in ensuring the best possible outcome. **Veterinary Disclaimer: This article is educational and is not a substitute for veterinary diagnosis or treatment. If you are concerned about your pet's health, please consult with your veterinarian.** ## Frequently Asked Questions ### 1. What is the difference between Pro BNP and BNP? The heart releases a prohormone that is split into two parts: the active B-type natriuretic peptide (BNP) and the inactive N-terminal fragment (NT-proBNP). The Pro BNP test measures the NT-proBNP fragment, which is more stable in the bloodstream and therefore easier to measure reliably. ### 2. Can I use a Pro BNP test at home? No. The Pro BNP test is a blood test that requires a veterinary visit. It is not an over-the-counter test that can be performed at home. Blood must be drawn by a professional and analyzed in a laboratory or with a veterinary point-of-care device [3]. ### 3. My cat has a heart murmur but is acting normal. Should I get a Pro BNP test? This is a common question. A Pro BNP test can be helpful in this situation. A normal result might provide some reassurance, but it cannot rule out structural heart disease. An elevated result would indicate myocardial stress and support the need for an echocardiogram [1]. Your veterinarian will help you decide if this test is appropriate for your cat. ### 4. If my dog's Pro BNP is normal, does that mean they don't have heart disease? Not necessarily. A normal Pro BNP result is a good sign, but it does not definitively rule out heart disease, especially in the early stages. The test has limits, and there is overlap between normal and diseased animals [1]. For example, a dog with mild MMVD might have a normal Pro BNP level [4]. ### 5. What can cause a false positive Pro BNP test? A false positive (elevated Pro BNP without primary heart disease) can occur in several situations. Conditions that stress the heart, such as severe systemic hypertension, anemia, or hyperthyroidism, can elevate NT-proBNP. Also, kidney disease can affect the clearance of the peptide, leading to higher blood concentrations [16]. ### 6. How does the Pro BNP test compare to an echocardiogram? An echocardiogram is the gold standard for diagnosing structural heart disease. It allows the veterinarian to see the heart's anatomy and function in real-time [3][7]. The Pro BNP test is a biochemical marker of stress. It is less accurate than an echocardiogram for diagnosing the specific cause of heart disease but can be a useful screening tool to determine if an echocardiogram is needed [1][3]. ### 7. Is the Pro BNP test useful for monitoring my dog's heart failure treatment? Yes, it can be. Serial measurements of NT-proBNP can help your veterinarian determine if the treatment is effectively reducing cardiac stress. A decreasing trend is generally a positive sign, while an increasing trend may indicate the disease is progressing despite therapy [2]. ### 8. Are there any risks associated with the Pro BNP test? The risks are minimal and are the same as for any routine blood draw. There is a small risk of bruising or bleeding at the needle site. Some pets may be anxious about the procedure. The benefits of the diagnostic information usually far outweigh the minimal risks. ## Sources [1] [Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.](https://pubmed.ncbi.nlm.nih.gov/21985136/) [2] [Exploratory analysis of gut microbiota and its association with peripheral blood immune cell populations in canine myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42304343/) [3] [The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats.](https://pubmed.ncbi.nlm.nih.gov/31317580/) [4] [Quantitative mitral regurgitation and conventional echocardiographic variables in canine myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42490935/) [5] [Canine radiography and echocardiography sensor fusion for deep learning-based detection and classification of myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42444957/) [6] [Altered Iron Metabolism in Dogs with Naturally Occurring Cardiac Disease.](https://pubmed.ncbi.nlm.nih.gov/42509791/) [7] [Echocardiographic Findings in Small-Breed Dogs With Myxomatous Mitral Valve Disease and the Severity of Mitral Regurgitation, Heart Size and Clinical Signs Myxomatous Mitral Valve Disease in Dogs.](https://pubmed.ncbi.nlm.nih.gov/42295688/) [8] [Rare stability in dogs with myxomatous mitral valve disease: Clinical observations of loop diuretic withdrawal after congestive heart failure.](https://pubmed.ncbi.nlm.nih.gov/42375430/) [9] [Deep Learning for Canine Cardiac Radiography: A Comprehensive Review of Automated Vertebral Heart Score Estimation.](https://pubmed.ncbi.nlm.nih.gov/42532333/) [10] [Influence of serum chloride concentrations on the renin-angiotensin-aldosterone system in dogs with congestive heart failure.](https://pubmed.ncbi.nlm.nih.gov/42324236/) [11] [Vertebral heart size and vertebral left atrial size reference intervals in 8 canine breeds.](https://pubmed.ncbi.nlm.nih.gov/42431230/) [12] [Feasibility and findings of different radiographic methods in diagnosing canine heartworm disease.](https://pubmed.ncbi.nlm.nih.gov/42375256/) [13] [Echocardiographic effects of a medetomidine-vatinoxan combination for sedating dogs without previously diagnosed heart disease.](https://pubmed.ncbi.nlm.nih.gov/42413260/) [14] [Spot urinary electrolytes are associated with decongestion and duration of hospitalization in dogs with acute left-sided congestive heart failure secondary to myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42385769/) [15] [Urine sodium concentration and diuretic responsiveness in dogs receiving orally administered loop diuretics for chronic congestive heart failure.](https://pubmed.ncbi.nlm.nih.gov/42302767/) [16] [Chronic kidney disease in a dog with hematologic and cardiovascular alterations: A case report.](https://pubmed.ncbi.nlm.nih.gov/42376422/) [17] [Computer-Generated 3D Models in Veterinary Student Education: Improving Radiographic Interpretation of Canine Congenital Heart Disease.](https://pubmed.ncbi.nlm.nih.gov/42507477/) [18] [Clinicopathological, epizootological, and morphological characterization of canine transmissible venereal tumor in dogs in Astana, Kazakhstan: A one-year Veterinary Diagnostic Center study.](https://pubmed.ncbi.nlm.nih.gov/42494696/) [19] [Association of component measurement variability and disease severity with variability of calculated mitral regurgitant fraction in dogs with myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42485707/) [20] [Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease.](https://pubmed.ncbi.nlm.nih.gov/42322454/) ## Related Clinical & Scientific Guides * [Thyroid Testing in Cats: Diagnosing Hyperthyroidism and T4 Fluctuations](/knowledge/veterinary-medicine/at-home-diagnostics/thyroid-testing-in-cats-diagnosing-hyperthyroidism-and-t4-fluctuations) * [Joint Fluid Analysis in Dogs: Diagnosing Septic Arthritis vs Immune-Mediated](/knowledge/veterinary-medicine/at-home-diagnostics/joint-fluid-analysis-in-dogs-diagnosing-septic-arthritis-vs-immune-mediated) * [Blood Glucose Curves for Diabetic Pets: In-Clinic vs At-Home Monitoring](/knowledge/veterinary-medicine/at-home-diagnostics/blood-glucose-curves-for-diabetic-pets-in-clinic-vs-at-home-monitoring)